Extendicare Inc (EXE.TO) saw a notable increase of 3.20% in its stock price during the last trading session, closing at CA$38.42.
In the latest trading session, Extendicare Inc experienced a significant uptick, reflecting positive investor sentiment. This rise can be attributed to the company's strategic initiatives and growth prospects in the healthcare sector.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.50B
P/E
27.1x
52W high
$37.71
52W low
$11.86
1W change
+0.49%
Beta
1.15
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 2.8% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.28
+2.8% Upside
Current Price
C$37.23
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
24.0%
Annualized
90-Day Vol
33.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$44.51
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$39.51 | C$36.37 โ C$42.93 |
| 60 trading days | C$41.94 | C$37.30 โ C$47.15 |
| 90 trading days | C$44.51 | C$38.56 โ C$51.38 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: For Canadian investors, Extendicare's recent performance highlights its potential as a solid investment in the growing healthcare market, particularly in home health care services.
3.20% Increase in Stock Price
Extendicare's stock rose to CA$38.42, reflecting a strong day for the company amid a competitive healthcare landscape.
Bull case
Extendicare's recent acquisitions and strong earnings growth indicate a solid business model. The company's focus on expanding home health care services positions it well for future growth, especially as demand in this sector continues to rise.
Bear case
Despite the positive movement, investors should stay cautious. The stock's P/E ratio of 27.375 suggests it may be overvalued compared to its earnings potential, and any market corrections could affect its share price.
Market Performance Overview
Extendicare Inc's stock closed at CA$38.42, marking a 3.20% increase from the previous trading session. This performance reflects growing confidence among investors, particularly in light of the company's strategic moves to enhance its service offerings in the healthcare sector.
Growth Drivers for Extendicare
The recent rise in Extendicare's stock can be attributed to its ongoing expansion in home health care services, which is becoming increasingly vital as the population ages. The company has made significant acquisitions, including the recent purchase of CBI Home Health, which is expected to strengthen its service capabilities and revenue streams.
Investor Considerations
While the stock's performance is encouraging, investors should consider the broader market conditions and the company's valuation metrics. With a P/E ratio of 27.375, potential investors should weigh the risks against the growth potential before making investment decisions. For more insights, visit our Extendicare stock page.
Advertisement
